Share

Latest Research, Industry, Medical and Scientific News

Dr. Larissa Rodriguez Wins Victor A. Politano Award from American Urological Association

Dr. Larissa V. Rodriguez, chair of the Department of Urology and the James J. Colt Professor of Urology at Weill Cornell Medicine and urologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, was named winner of the 2024 Victor A. Politano Award by the American Urological Association.  The award is presented annually to an individual for outstanding achievements in the field of urinary incontinence. Dr. Rodriguez is being honored for her work to advance the treatment of urinary incontinence through pioneering research and compassionate patient care. She will be recognized at the association’s annual meeting in San Antonio, Texas in May. Read more.

Source: Weill Cornell Medicine, February 8, 2024

Could Botox Injections Help Patients…Down There? A New Study Suggests That Botox Can Help with Fecal Incontinence

Researchers are testing rectal injections of Botox to see whether they might help patients manage fecal incontinence—so far, results are promising. If future studies confirm success, doctors could provide patients with new ways to manage this hard-to-control condition.  In a randomized, double-blind, placebo-controlled study, researchers treated nearly 200 patients for fecal incontinence using Botox or a placebo. Ninety-six patients received Botox, and 95 received the placebo treatment after nine patients withdrew from the trial before receiving injections.  Read more.

Source: MDLinx, January 29, 2024

UroCure Expands SUI Sling Portfolio with the Nationwide Launch of the ArcSP and ArcTO Slings

UroCure and LiNA Medical USA are pleased to announce the nationwide launch of UroCure’s two latest innovations of surgical solutions for female stress urinary incontinence: the ArcSP Suprapubic Sling System and the ArcTO Transobturator Sling System.  These two additions complement the current UroCure ArcTV® Transvaginal Sling on the market. ArcSP will now provide a top-down, retropubic approach and ArcTO will accommodate surgeons that prefer an outside-in, transobturator approach. All three systems are based on AMS’ best-in-class slings, while incorporating UroCure’s laser cut sling with its patented stabilizing suture. The absorbable stabilizing suture is a key innovation of UroCure’s sling designed to maintain its open pore structure and to protect the sling from deformation during placement, tensioning, and sheath removal. Read more.

Source: PRNewswire, January 25, 2024

Unveiling the Link Between Financial Strain and Lower Urinary Tract Symptoms

The association between financial strain and lower urinary tract symptoms LUTS and impact is caused by a lack of health care utilization and comorbidities, according to a recent study published in the American Journal of Obstetrics & Gynecology. LUTS such as urinary incontinence (UI), nocturia, frequent urination, or difficulties with bladder emptying often adversely impact quality of life and increase the risks of depression and anxiety. Data has indicated the risk of LUTS is increased by social determinants of health (SDOH) such as housing insecurity, food insecurity, financial insecurity, difficulty finding employment, and unreliable transportation. Read more.

Source: Contemporary OB/GYN, January 19, 2024

Understanding the Link Between Urinary Incontinence in Women and Disability Risk: Insights from Recent Medical Research

Urinary incontinence, a condition that affects millions of women worldwide, may have more severe implications than previously thought. A recent study from the Rush University Medical Center has added a new dimension to our understanding of this common health issue. According to the study, urinary incontinence in women is linked with a higher risk of disability. This finding is significant and has implications for both the management and treatment of urinary incontinence in women. Read more.

Source: Medriva, January 12, 2024

female doctor

Medical Device Maker Boston Scientific to Buy Axonics for $3.7 Billion

Medical device maker Boston Scientific (BSX.N), said on Monday it had agreed to buy Axonics Inc (AXNX.O), for $3.7 billion, gaining access to devices used to improve bladder function.  The deal marks Boston Scientific’s entry into sacral neuromodulation, a minimally invasive procedure used in the treatment of overactive bladder and fecal incontinence, and is the latest in efforts to scale up its urology business. Read more.
Source: Reuters, January 8, 2024